Share Email Print

Journal of Biomedical Optics • Open Access • new

Challenges and opportunities in clinical translation of biomedical optical spectroscopy and imaging
Author(s): Brian C. Wilson; Michael Jermyn; Frédéric Leblond

Paper Abstract

Medical devices face many hurdles before they enter routine clinical practice to address unmet clinical needs. This is also the case for biomedical optical spectroscopy and imaging systems that are used here to illustrate the opportunities and challenges involved. Following initial concept, stages in clinical translation include instrument development, preclinical testing, clinical prototyping, clinical trials, prototype-to-product conversion, regulatory approval, commercialization, and finally clinical adoption and dissemination, all in the face of potentially competing technologies. Optical technologies face additional challenges from their being extremely diverse, often targeting entirely different diseases and having orders-of-magnitude differences in resolution and tissue penetration. However, these technologies can potentially address a wide variety of unmet clinical needs since they provide rich intrinsic biochemical and structural information, have high sensitivity and specificity for disease detection and localization, and are practical, safe (minimally invasive, nonionizing), and relatively affordable.

Paper Details

Date Published: 6 March 2018
PDF: 13 pages
J. Biomed. Opt. 23(3) 030901 doi: 10.1117/1.JBO.23.3.030901
Published in: Journal of Biomedical Optics Volume 23, Issue 3
Show Author Affiliations
Brian C. Wilson, Princess Margaret Cancer Ctr. (Canada)
Michael Jermyn, Thayer School of Engineering at Dartmouth (United States)
Frédéric Leblond, Ecole Polytechnique de Montréal (Canada)
CRCHUM (Canada)

© SPIE. Terms of Use
Back to Top